Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel Vaccine Candidates against Brucella melitensis Identified through Reverse Vaccinology Approach

19 Oct 2015

Abstract excerpt

Global health therapeutics is a rapidly emerging facet of postgenomics medicine. In this connection, Brucella melitensis is an intracellular bacterium that causes the zoonotic infectious disease, brucellosis. Presently, no licensed vaccines are available for human brucellosis. Here, we report the identification of potential vaccine candidates against B. melitensis using a reverse vaccinology approach. Based on a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brucella: diagnosis, epidemiology, treatment
Share to Monoclonal and Polyclonal Antibodies Research
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26479901
DOI: 10.1089/omi.2015.0105

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel Vaccine Candidates against Brucella melitensis Identified through Reverse Vaccinology ApproachPMID 26479901Read ↗

In silico designed novel multi-epitope mRNA vaccines against Brucella by targeting extracellular protein BtuB and LptDSemantic proximity Read ↗

Analyses of Brucella Pathogenesis, Host Immunity, and Vaccine Targets using Systems Biology and BioinformaticsSemantic proximity Read ↗

Screening of potential vaccine candidates against pathogenic Brucella spp. using compositive reverse vaccinologySemantic proximity Read ↗

An In-depth Genomic Investigation to Design a Multi-Epitope Based Vaccine against BrucellosisSemantic proximity Read ↗

A Novel Pan-Genome Reverse Vaccinology Approach Employing a Negative-Selection Strategy for Screening Surface-Exposed Antigens against leptospirosisSemantic proximity Read ↗

In Silico Prediction of a Multitope Vaccine against Moraxella catarrhalis: Reverse Vaccinology and ImmunoinformaticsSemantic proximity Read ↗

Subtractive Proteomics and Reverse-Vaccinology Approaches for Novel Drug Target Identification and Chimeric Vaccine Development against Bartonella henselae Strain Houston-1Semantic proximity Read ↗

Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosisSemantic proximity Read ↗

Discovery of Novel Leptospirosis Vaccine Candidates Using Reverse and Structural VaccinologySemantic proximity Read ↗

Reverse Vaccinology and Immune Simulation of a Novel Multiepitope Vaccine Targeting <em>Brucella </em>VirulenceSemantic proximity Read ↗

Novel dual-pathogen multi-epitope mRNA vaccine development for Brucella melitensis and Mycobacterium tuberculosis in silico approachSemantic proximity Read ↗

Putative novel B-cell vaccine candidates identified by reverse vaccinology and genomics approaches to control Acinetobacter baumannii serotypesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.